ResearcherSun Yat-sen UniversityActive in the last 2 years

Su‐Li Zhu

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 8 November 2026

Matched on OpenAlex author ID A5109718322. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 2

Papers, trials and grants by year

2024: 1 paper

Papers 1

A novel DDIT3 activator dehydroevodiamine effectively inhibits tumor growth and tumor cell stemness in pancreatic cancer. Co-author DOI 10.1016/j.phymed.2024.155377 ↗

Closest collaborators

The 2 strongest of 2 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Xing-Wang Zhou · 1 shared paper, 2024 · strength 0.24
- Paper A novel DDIT3 activator dehydroevodiamine effectively inhibits tumor growth and tumor cell stemness in pancreatic cance… DOI 10.1016/j.phymed.2024.155377 ↗
Lijuan Deng · 1 shared paper, 2024 · strength 0.24
- Paper A novel DDIT3 activator dehydroevodiamine effectively inhibits tumor growth and tumor cell stemness in pancreatic cance… DOI 10.1016/j.phymed.2024.155377 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.